Awards & Announcements, In the News Kate Fernandes 9/10/25 Awards & Announcements, In the News Kate Fernandes 9/10/25 Lactiga Wins NIH Backing for First-in-Class Breastmilk-Derived Antibody in Inflammatory Bowel Disease Read More In the News Kate Fernandes 9/10/25 In the News Kate Fernandes 9/10/25 Kenox and Lactiga partner on sIgA therapies for immunodeficiency Read More In the News Kate Fernandes 9/10/25 In the News Kate Fernandes 9/10/25 As good as gold Read More In the News, Awards & Announcements Rik Mehta 2/3/25 In the News, Awards & Announcements Rik Mehta 2/3/25 Lactiga Secures Multi-Year, Multi-Million Dollar Grant Read More In the News Rik Mehta 1/5/25 In the News Rik Mehta 1/5/25 ValiantCEO | Viraj Mane, Lactiga – Developing Novel Antibodies for Mucosal Infections in Rare Immunodeficiencies Read More Publications, In the News Rik Mehta 9/25/23 Publications, In the News Rik Mehta 9/25/23 In vivo antiviral efficacy of LCTG-002, a pooled, purified human milk secretory IgA product, against SARS-CoV-2 in a murine model of COVID-19 Read More In the News, Awards & Announcements Rik Mehta 8/14/23 In the News, Awards & Announcements Rik Mehta 8/14/23 Lactiga Gets FDA Rare Pediatric Disease Designation for CVID Therapy Read More In the News Rik Mehta 10/6/22 In the News Rik Mehta 10/6/22 Lactiga in the Toronto Star Read More In the News, Awards & Announcements Rik Mehta 9/21/22 In the News, Awards & Announcements Rik Mehta 9/21/22 Lactiga Therapeutics Raises $1.6M USD in Oversubscribed Pre-Seed Round, Secures $350k in Research Grants Read More In the News, Awards & Announcements Rik Mehta 9/21/22 In the News, Awards & Announcements Rik Mehta 9/21/22 Lactiga Therapeutics Raises $1.6M USD in Oversubscribed Pre-Seed Round, Secures $350k in Research Grants Read More In the News Rik Mehta 9/7/22 In the News Rik Mehta 9/7/22 Post-mRNA vaccine antibodies in breast milk raises protective potential for babies, and possibly adults Read More In the News Rik Mehta 10/5/21 In the News Rik Mehta 10/5/21 Not just for babies: Biotech startup taps breast milk for COVID treatment that keeps up as virus mutates Read More In the News Rik Mehta 6/13/21 In the News Rik Mehta 6/13/21 How Biotech Startup Lactiga Uses DocSend to Show Traction Read More In the News Rik Mehta 6/12/21 In the News Rik Mehta 6/12/21 Lactiga Featured in the Globe and Mail Read More In the News Rik Mehta 6/9/21 In the News Rik Mehta 6/9/21 Got milk COVID-19 antibodies? Read More In the News, Awards & Announcements Rik Mehta 11/2/20 In the News, Awards & Announcements Rik Mehta 11/2/20 Checkmate Capital Group Completes Seed Investment in Lactiga, Inc. Read More In the News, Awards & Announcements Rik Mehta 10/14/20 In the News, Awards & Announcements Rik Mehta 10/14/20 Lactiga Announces NIH-Funded Partnership with Mount Sinai to Advance its Patented Biologic for COVID-19 Treatment Read More In the News, Awards & Announcements Rik Mehta 9/1/20 In the News, Awards & Announcements Rik Mehta 9/1/20 LACTIGA USES DOCSEND DATE ROOMS FOR PROACTIVE AND PERSONALIZED FUNDRAISING Read More
Awards & Announcements, In the News Kate Fernandes 9/10/25 Awards & Announcements, In the News Kate Fernandes 9/10/25 Lactiga Wins NIH Backing for First-in-Class Breastmilk-Derived Antibody in Inflammatory Bowel Disease Read More
In the News Kate Fernandes 9/10/25 In the News Kate Fernandes 9/10/25 Kenox and Lactiga partner on sIgA therapies for immunodeficiency Read More
In the News, Awards & Announcements Rik Mehta 2/3/25 In the News, Awards & Announcements Rik Mehta 2/3/25 Lactiga Secures Multi-Year, Multi-Million Dollar Grant Read More
In the News Rik Mehta 1/5/25 In the News Rik Mehta 1/5/25 ValiantCEO | Viraj Mane, Lactiga – Developing Novel Antibodies for Mucosal Infections in Rare Immunodeficiencies Read More
Publications, In the News Rik Mehta 9/25/23 Publications, In the News Rik Mehta 9/25/23 In vivo antiviral efficacy of LCTG-002, a pooled, purified human milk secretory IgA product, against SARS-CoV-2 in a murine model of COVID-19 Read More
In the News, Awards & Announcements Rik Mehta 8/14/23 In the News, Awards & Announcements Rik Mehta 8/14/23 Lactiga Gets FDA Rare Pediatric Disease Designation for CVID Therapy Read More
In the News, Awards & Announcements Rik Mehta 9/21/22 In the News, Awards & Announcements Rik Mehta 9/21/22 Lactiga Therapeutics Raises $1.6M USD in Oversubscribed Pre-Seed Round, Secures $350k in Research Grants Read More
In the News, Awards & Announcements Rik Mehta 9/21/22 In the News, Awards & Announcements Rik Mehta 9/21/22 Lactiga Therapeutics Raises $1.6M USD in Oversubscribed Pre-Seed Round, Secures $350k in Research Grants Read More
In the News Rik Mehta 9/7/22 In the News Rik Mehta 9/7/22 Post-mRNA vaccine antibodies in breast milk raises protective potential for babies, and possibly adults Read More
In the News Rik Mehta 10/5/21 In the News Rik Mehta 10/5/21 Not just for babies: Biotech startup taps breast milk for COVID treatment that keeps up as virus mutates Read More
In the News Rik Mehta 6/13/21 In the News Rik Mehta 6/13/21 How Biotech Startup Lactiga Uses DocSend to Show Traction Read More
In the News Rik Mehta 6/12/21 In the News Rik Mehta 6/12/21 Lactiga Featured in the Globe and Mail Read More
In the News, Awards & Announcements Rik Mehta 11/2/20 In the News, Awards & Announcements Rik Mehta 11/2/20 Checkmate Capital Group Completes Seed Investment in Lactiga, Inc. Read More
In the News, Awards & Announcements Rik Mehta 10/14/20 In the News, Awards & Announcements Rik Mehta 10/14/20 Lactiga Announces NIH-Funded Partnership with Mount Sinai to Advance its Patented Biologic for COVID-19 Treatment Read More
In the News, Awards & Announcements Rik Mehta 9/1/20 In the News, Awards & Announcements Rik Mehta 9/1/20 LACTIGA USES DOCSEND DATE ROOMS FOR PROACTIVE AND PERSONALIZED FUNDRAISING Read More
